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Abstract 
Purpose 
Investigating the feasibility of using low-cost commercially available silica beads as novel 
thermo-luminescence dosimeters (TLD) for postal dosimetry audit.  
Methods 
A mail-based dosimetry audit was designed to assess the positional and dosimetric accuracy of 
SABR-lung treatment delivery using alanine and EBT3-film, placed in a CIRS-anthropomorphic 
thorax phantom. In conjunction, the silica beads were dosimetrically characterized as TLDs and 
cross-calibrated against the alanine. A CT-scan of the phantom with pre-delineated volumes was 
sent to 20 RT centres and used to create a SABR plan using local current protocols and 
techniques. The silica beads were held in an insert, designed to match that of the alanine holder 
and ionisation chamber to give the same measurement length. The doses determined by the silica 
beads were compared to those measured by alanine, the local ionisation chamber, film and the 
TPS calculation.  
Results 
The mean percentage difference between the doses measured by the silica beads and the 
calculated doses by the TPS was found to be 0.7% and differed by 0.6%, 0.7 %, and 1.3 % from 
the alanine, film and local ionisation chamber measurements respectively. 
Conclusions 
Results obtained with the silica beads agree well with those obtained from conventional detectors 
including alanine, film and ionisation chambers. This together with the waterproof and inert 
characteristics and minimal dose fading associated with silica bead TLDs confirm their potential 
as a postal dosimetry audit tool in both water and plastic phantoms which could withstand 
challenges of temperature and humidity variation, as well as postal service delays. 
Keywords: Dosimetry audit, radiotherapy, SABR, Thermoluminescent detectors  
1. Introduction  
Radiotherapy audit provides an external independent assessment of the dosimetry and can help to 
identify possible improvements and also find issues which may need addressing immediately [1, 
2,  3, 4,  5, 6].  
Although the use of thermoluminescence dosimeters (TLD) as the standard tool for postal dose 
audits is common practice [7, 8, 3, 9] TLDs require improvements to face the new challenges 
introduced by advanced radiotherapy techniques, and recently several other types of detector 
have been used for audit including seven29 array (PTW-Freiburg GmbH, Germany) and 
InLight® nanoDot OSLD system [4, 5, 10]. Advanced radiotherapy techniques very often use 
small radiation fields with high dose gradients [11, 12] which introduce further challenges in 
dosimetry. The common and well-established small TLDs, such as 1 mm
3
 LiF: Mg, Ti have been 
designed for traditional radiotherapy practice with an upper dose range limit of approximately 10 
Gy and therefore are not suitable for dose evaluation of high dose advanced techniques such as 
SABR. Furthermore, for postal dosimetry audit of such techniques, especially when complex 
dose distributions and field arrangements are used, the best detector would be a micro detector 
with a linear response to a large dynamic dose range and ideally be a detector that also has a very 
low fading, non-hygroscopic nature and is robust, as irradiation and postage return may take 
some time [12, 13]. 
Silica beads have previously been characterised as novel high spatial resolution micro TLDs [14, 
15, 16, 17, 18]. The particular silica beads employed have several potentially favourable physical 
characteristics as dosimeters in postal dosimetry audit of advanced radiotherapy. They are small 
in size (2 mm diameter and 1 mm thickness), chemically inert, inexpensive, readily available, 
and reusable. They exhibit minimal fading compared with LiF: Mg, Ti TLDs, have a high 
sensitivity and a large dynamic dose range that remains linear (R
2
 ≥ 0.999) from 1 cGy to 50 Gy 
(i. e. the investigated dose range). The dose response has been found to be independent of dose 
rate and incidence of beam angle which makes it suitable for delivery techniques such as VMAT 
and non-coplanar beams. Although silica beads are silicon based TLDs and not soft-tissue 
equivalent, they have shown a close to uniform response over the MV photon energy range 
which is commonly used in advanced radiotherapy techniques. These properties suggest their 
practical use as TL dosimeters for radiotherapy dosimetry.  
In this work the feasibility of using silica bead TLDs for the lung radiotherapy postal dosimetry 
audit is assessed in conjunction with the UK SABR Lung Consortium dose audit run by the 
Consortium QA group. Silica beads were placed in the CIRS phantom where heterogeneity is 
present and the performance of the silica beads in a non-equilibrium condition (near the 
tissue/lung interfaces) was evaluated.  
Stereotactic ablative body radiotherapy (SABR) is an advanced radiotherapy technique that uses 
low fractionation, high dose treatments, stereotactically directed to the tumour. For example, in 
SABR for lung a prescription dose of 18 Gy/fraction (in 3 fractions) to the 80% isodose is 
typically prescribed [19]. In such a situation where a high dose is delivered in a few fractions, 
there are fewer opportunities to correct or adapt the treatment dose. An error in any single 
fraction would have a larger proportional impact and therefore, the dosimetric accuracy is 
expected to have a greater effect on radiotherapy outcome. It is therefore essential that such 
treatments be verified by undertaking appropriate quality assurance (QA). Dose errors in such 
cases of the order of 5% can result in 10 to 20% changes in tumour control probability and up to 
20 to 30% changes in normal tissue complication probabilities [20].  
The audit was designed to assess the positional and dosimetric accuracy of SABR lung treatment 
delivery across UK. This was achieved with the use of alanine pellets and EBT3 GafChromic 
film dosimetry, placed in a CIRS lung phantom [21, 22]. 20 volunteer centres within the UK 
collaborated with this feasibility study. 
2.  Material and methods  
2.1 Silica beads 
A batch of transparent silica beads, 2 mm diameter and 1 mm thick outer shell (Petite: Stock#: 
G42010, Mill Hill, Japan) with material composition (by weight): C-8.93%, O-42.18%, Na-
10.55%, Al-1.3%, Si-33.62%, K-1.09%, Ca-1.92%, Fe-0.37% [15] was selected for this work. 
The silica beads were initially produced as jewellery silica beads and preparation was required 
for them to be used as TLDs. The silica beads were acid washed in an ultrasonic bath in order to 
remove the surface-applied colouration and were screened for variation in mass using an Ohaus 
Adventurer Analytical balance. Overall, 280 silica beads of mass 3.4 ± 0.1 mg were used. For 
each measurement, 20 silica beads were threaded along a cotton yarn, in order to have the same 
effective length of measurement as a NE2571 graphite-walled cylindrical ionisation chamber (23 
mm). In this arrangement, a high resolution dose profile measurement was obtained as well as 
the mean value of all 20 silica beads were comparable to the dose measured by each centre’s 
local ionisation chambers. They were then loaded into a custom-built insert. 
2.2 Silica bead readout 
A Harshaw 4500 planchet TLD reader was employed to readout the silica beads at 300 ºC at a 
ramp-rate of 35 ºC/s following a preheat treatment of 140 ºC for 10 s. To consider the post 
radiation time delay for a potential postal service, readings were only obtained following a post-
irradiation delay of 10 days. Between each use, the beads were subsequently annealed for 1 h at 
400 °C and then kept 24 h at room temperature under dark conditions to ensure they were 
stabilised prior to the next irradiation. A detailed description of the preparation and annealing 
procedure has previously been published [14]. 
2.3 Silica beads holder insert  
Given the phantom was designed for film and ionisation chamber dosimetry, custom made 
inserts matching the external shape of the NE2571 type ionisation chamber were made from 
tissue equivalent material (PEEK) in order to hold the silica bead TLDs and the alanine in an 
identical measurement position. All the inserts were coded to keep track of individual silica 
beads. Three inserts and a stem were packed in a black card box (figure 1) and posted to each 
centre at the same time as the CIRS phantom, alanine and film were sent by the SABR 
consortium audit team.  
2.4 CIRS Lung phantom 
Five CIRS IMRT Thorax Phantoms (The CIRS Model 002LFC) (figure 1) were used for the 
Lung SABR dose audit. This is an anthropomorphic phantom with lungs and a spinal cord in a 
thorax shaped solid water, which can be used for commissioning as well as comparison of TPS 
calculated plans and measurements.  
A CT scan of a CIRS lung phantom was performed by the SABR consortium audit team prior to 
the national audit with 1.25 mm slice spacing and thickness. Volumes relating to the internal 
target volume (ITV) and the position of the alanine pellets were pre-delineated. This CT scan set 
was sent to all centres and was loaded into their respective treatment planning system. The CT 
calibration curves were sufficiently similar to justify this single scan and uncertainty was 
estimated to be no larger than 0.5% [23].  
 
Figure 1: (a), The CIRS Lung phantom with silica bead insert shown by a red circle. (b), the 
silica bead holder, in which silica beads are loaded. (c). schematic view of silica bead insert, and 
(d), 20 silica bead TLDs arranged on a piece of cotton yarn.     
2.5 Audit Documents  
In addition to dosimeters, the following documents, dosimetry protocols and instruction sheets 
were prepared and sent to each centre: 
 A dosimetry audit protocol, which was prepared by the SABR consortium audit team, 
provided explanation of the phantom description, handling, CT-scanning and planning, 
EBT3 GafChromic film dosimetry and procedures for returning film for processing, as 
well as return of the alanine dosimeters to the National Physical Laboratory for readout. 
(b) 
(c) 
(d) 
Silica bead insert (a) 
 A GafChromic film irradiation record form 
 An alanine irradiation record form 
 Silica beads introductory document  
 Silica beads dosimetry instructions and irradiation record form 
2.6 Measurement procedure 
2.6.1  Silica beads calibration  
This batch of silica beads has been dosimetrically characterised in the previous studies and the 
details of characterisation measurements are published in earlier publications [14 and 15].  
Linearity of dose response covering the range of radiotherapy dose levels (1cGy to 50Gy), had a 
correlation coefficient of R
2
 ≥ 0.999; therefore, the large dose differences between reference 
dose measurement and the audit dose levels can be considered to have a negligible calibration 
error. Energy response was fairly uniform across the MV photon beams and the maximum 
percentage difference compared to that obtained at 6 MV photons being -3.8% for 15 MV 
photons [15]. The energy response is considered of relevance for the use of dosimeters in postal 
audit situations where each institution may have slightly different quality index (QI) for their 
respective photon energies thus ensuring that the calibration may still be considered valid when 
same nominal beam energy is used.  
The silica beads had a batch homogeneity of 8% (SD = 1) and so individual calibration factors 
were determined. This relative calibration was performed in a 6 MV clinical photon beam 
(TPR20/10 = 0.670) with a field size of 10 × 10 cm
2
. The calibration dose was 10 Gy at 5 cm 
depth in a Solid-Water® phantom. This beam quality was chosen as all radiotherapy centres 
employed 6 MV photon beams for their respective audit plans. A detailed description of the 
calibration procedure has been published previously [17].  
2.6.2 Absolute dose measurements using alanine dosimeters 
For absolute dosimetry, the silica beads were cross calibrated against alanine dosimeters in 
reference conditions. To perform absolute dosimetry with sufficient accuracy using alanine 
pellets, a dose of greater than 10 Gy is ideally required [24]. At 10 Gy, the uncertainty associated 
with the calibration of alanine dosimeters is 0.85% (SD = 1) and the pellet to pellet 
reproducibility is 0.5% (SD = 1) [24, 25]. Centres were therefore requested to irradiate a set of 
silica beads at a dose of 10 Gy at the same beam energy and under the same experimental 
conditions. The local ionisation chamber was also given 10Gy under these conditions.  
The irradiated alanine pellets were analysed by the National Physical Laboratory using an EPR 
spectrometer and the results were reported in terms of dose (Gy).    
2.6.3  SABR Plan  
Each centre created a SABR plan on the scan of the CIRS lung phantom using their current 
planning protocol and technique. The plan covered the Planning Target Volume (PTV), which 
contained film, 9 alanine pellets and thus also the silica beads that in turn sit along the central 
measurement axis of the alanine pellets. The position of the silica beads were close to the film, 
but not identical positioning (figure 2).  
The setup of the   SABR plan was first checked with the local ionisation chamber by placing the 
chamber in the posterior part of the left lung. An identical irradiation was then given to a set of 
silica beads. The phantom was next dismantled, the gafchromic film and alanine pellets were 
then put in position and the measurement was performed for the main audit.  
The film analysis was performed by aligning the measured and calculated dose grids using the 
phantom pin coordinates (±1 mm). The mean dose for the areas enclosed by the calculated 100% 
isodose line, in both the measured and calculated dose distributions were compared to alanine 
and silica bead dose measurements. The detailed procedure for film and alanine irradiation and 
analysis is given in a separate paper [22]. 
 
 
Figure 2:  An example of the dose distribution of the treatment plan, which covered the PTV 
and contained 9 alanine pellets, film or a string of silica beads that sit along the central 
measurement axis of the alanine pellets (an overlapped picture of 20 silica beads threaded on a 
black cotton yarn and 9 alanine pellet outlines are shown to clarify the position of silica beads 
relative to the alanine pellets). The alanine pellets are positioned in the effective volume of an 
NE2571 ionisation chamber in turn.  
2.6.4  Uncertainty analysis 
Three major sources of uncertainty in the dose determination using the bead TLDs were 
identified: 
Film  
Alanine pellets  
Silica beads  
 uncertainties associated with the calibration of the silica bead TLDs consistency against 
the alanine dosimeters  
 uncertainties in the determination of individual sensitivity correction factors for the silica 
bead TLDs 
 the uncertainty associated with the silica bead TLD themselves: linearity, fading during 
the readout process, and the TLD readout process  
Dose response linearity, fading, and energy corrections factors are commonly applied for TLD 
analysis [26]. However, the fading and energy correction factors were negligible for this work as 
the absolute dose calibrations for the silica beads were performed on the day of read out and all 
treatment plans utilised 6 MV energy. Small variations of quality index for this nominal energy 
among facilities was considered to have a minimal effect. The uncertainty budgets for the silica 
bead TLDs quantified in table 1. 
Table 1: The uncertainty budgets for the individual silica bead TLDs 
Source of uncertainty  Relative standard uncertainty (%), SD = 2 
Cross calibration of the TLD against alanine 
dosimeters  
1.7 
Determination of individual sensitivity 
correction factors for each TLD 
1.7 
Dose response linearity of silica beads 0.1 
TLD reading process 2 
Calculated standard uncertainty (quadratic 
summation) 
3.13 
 
With regard to the TLD readout process standard deviations of the silica bead TLDs are derived 
from the response of dosimeters to the same dose. The reproducibility of each individual TLD 
was found to depend on the stability of the TLD reader output as well as consistency in the 
positioning of beads on the planchet and annealing procedure [13, 14, and 15].  
The overall uncertainty associated with alanine dosimetry during this audit ranged from 2.0 to 
1.8% (10–24 Gy; SD = 2) and 2.6% for the film [22]. 
No phantom dependent correction has been applied. The geometry and density variations 
between five identical phantoms were checked and found to be negligible.  
The analysis of percentage differences of silica beads results with alanine, ionisation chamber 
and TPS may be affected by small errors in the positioning of the TLD holders. For the majority 
of plans the dose distribution within the treatment volume is uniform and any movement of the 
TLD would change the dose by up to a maximum of 2.2% for a 5 mm shift from the position 
stated, which is the highest possible deviation of dose distribution across the 5 mm diameter 
alanine pellet. 
3. Results 
22 SABR treatment plans from 20 centres were measured. Delivery techniques varied amongst 
the centres; 6 centres used conformal radiotherapy, 11 centres used Volumetric Modulated Arc 
Therapy (VMAT) and 3 centres used CyberKnife. All centres employed 6 MV photon beams. 
The silica bead results were analysed after correction for the calibration against the alanine 
reference measurement. The percentage differences of SABR plan doses measured with silica 
beads from alanine, film, local ionisation chamber and TPS predicted doses are shown in figure 
3. Figure 4 is showing an example of dose profile across the active volume of ionisation chamber 
obtained by silica beads and alanine pellets in comparison with the TPS.  
 
Figure 3: A histogram of comparison between silica bead results and measurements with 
alanine, ionisation chamber, film and TPS expected doses. 
 
Figure 4: Dose profile obtained by silica beads and alanine pellets in comparison with the TPS 
(Expanded uncertainty (SD=2) indicated). 
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4. Discussion 
In this work, silica beads were used for a feasibility study of a dosimetry audit of SABR lung 
treatments performing point dose measurements in a CIRS phantom where heterogeneity is 
present and the performance of the silica beads in a non-equilibrium condition (near the 
tissue/lung interfaces) was evaluated.  
Their performance was compared with alanine, ionisation chamber and film dosimeters. The 
mean percentage difference between the doses measured by the silica beads and the calculated 
doses by the TPS were found to be 0.7% (±2.0) and differed by 0.6% (±1.5), 0.7 % (±2.3) and 
1.3 % (±1.4) from alanine, film and local ionisation chamber measurements respectively. 
Although these levels of discrepancy are within the measurement uncertainty, all the cases with 
greater than 2% difference underwent a detailed analysis of root cause. It was found that dose 
distributions in the treatment plan for these cases were less homogenous, such that they had up to 
a 2.2% standard deviation of dose within a 5 mm
2
 area (figure 4 is giving a comparison of dose 
profile across the active volume of ionisation chamber calculated by the TPS and measured by 
alanine and silica beads). Setup variation between the silica beads and alanine measurements 
may therefore be the main contributing factor to these larger differences. This may have 
happened due to placement and removal of the film. 
By looking at the histogram of comparison between silica bead results and measured values by 
other detectors/TPS calculation, in fig. 3, the positive value of mean percentage differences may 
suggest that, like other silicon based detectors [27, 28] the silica beads slightly over respond 
(0.6% on average compared to alanine in this study). This was also noticed in previous work, 
[16, 17].  However, all the values are within measurement uncertainty and so it is not possible to 
form a firm conclusion. The density of silica beads is less than that of diodes [15], which are 
routine dosimeters for clinical dosimetry [29], hence if there is over response it is expected to be 
much less than that of the diodes which is reported by Huang et al. [30].  
The range of doses used by the centres in this audit varied from approximately 15 to 27 Gy. The 
large dynamic dose range of silica bead is particularly advantageous in these circumstances, 
compared to other well-established TLD materials, such as 1 mm
3
 LiF: Mg, Ti cubes, which are 
designed for conventional radiotherapy dose range with an upper dose range limitation of 10 Gy. 
The independence of the silica bead dose response to beam angle and dose rate is of importance 
in diverse delivery techniques as used in this study and compares favourably with other detectors 
such as diamond detectors and ionisation  chamber 2D-arrays with a dose rate and directional 
dose response [10, 31, 32]. 
Along with these encouraging results, the inert nature and low fading of these silica bead TLDs 
suggest that they may be a suitable tool for postal dose audits without concerns regarding the 
temperature, humidity and handling conditions that an audit parcel may experience. When a 
large number of TL dosimeters for such applications are required a further advantage is the low 
cost and ease of availability. The small size and inert nature of them is also of particular interest 
for possibility of using them as in-vivo dosimeters which is part of our future work. 
5. Conclusions  
The silica beads have been evaluated for their use in postal dosimetry audit by undertaking a 
feasibility study alongside an audit conducted at 20 radiotherapy centres within the UK assessing 
positional and dosimetric accuracy of SABR lung treatment delivery. Their performance has 
been compared to alanine, ionisation chamber and film dosimeters and doses predicted by the 
treatment planning systems and agreed well with the above-mentioned dosimetry systems. 
Dosimetric properties including linear response over a wide range of doses, low fading, dose rate 
and angular independency in addition to their reusability, chemically inert nature and low cost is 
advantageous for their application in postal dosimetry services. The results therefore confirm the 
potential of the silica bead TLD systems as dosimeters for postal audit for such techniques as 
SABR. 
The results are encouraging and their application in postal dosimetry services is an example 
where the low fading, non-hygroscopic nature and robustness is important where irradiation and 
postage return may take some time. In particular, where more complex dose distributions and 
field arrangements may be required to be measured [9, 12]. 
Acknowledgement  
Authors would like to express a special appreciation and thanks to the Medical Physics 
Department of the Royal Surrey County Hospital, the NPL Radiation Dosimetry group, and the 
UK radiotherapy departments who volunteered to irradiate our dosimeters during the Lung 
SABR national dosimetry audit; St Barts, Bristol, Clatterbridge, Guys and St. Thomas’, Hull, 
Ipswich, Leeds, Leicester, Manchester, Middlesbrough, Mount Vernon, Newcastle, Norfolk & 
Norwich, Nottingham, Oxford, Peterborough, Royal Marsden, Sheffield and UCLH radiotherapy 
departments. 
SJ would also like to convey thanks to the University of Surrey for the Overseas Research 
Scholarship and Schlumberger Foundation for the Faculty for The Future scholarship. 
References:  
                                                 
[1] Nisbet A., Thwaites D.I. 1997. A dosimetric intercomparison of electron beams in UK radiotherapy centres Phys 
Med Biol, 42, 2393–2409.   
[2] Thwaites D. I., Scalliet P., Leer J. W. and Overgaard J. 1995. Quality assurance in radiotherapy: European 
society for therapeutic radiology and oncology advisory report to the commission of the European union 
for the Europe against cancer programme Radiother. Oncol. 35 61–73 
[3] Izewska J., Andreo P., Vatnitsky S., Shortt K.R. 2003. The IAEA/WHO TLD postal dose quality audits for 
radiotherapy: a perspective of dosimetry practices at hospitals in developing countries Radiother Oncol, 69, 
91–97. 
[4] Clark C. H. et al., 2014. A multi-institutional dosimetry audit of rotational intensity-modulated radiotherapy 
Radiother Oncol, 113, 272–278 http://dx.doi.org/10.1016/j.radonc.2014.11.015 
[5] Ibbott G. S., Thwaites D. I. 2015. Audits for advanced treatment dosimetry in Journal of Physics: Conference 
Series 
                                                                                                                                                             
[6]  Clark C H, Aird E G A, Bolton S, Miles E A, Nisbet A, Snaith J A D, Thomas R A S, Venables K and Thwaites 
D I, 2015. Radiotherapy dosimetry audit: three decades of improving standards and accuracy in UK clinical 
practice and trials Br. J. Radiol. 88 20150251 
[7] Aguirre JF, Tailor R, Ibbott G, Stovall M, Hanson, W. 2002. Thermoluminescence dosimetry as a tool for the 
remote verification of output for radiotherapy beams: 25 years of experience. In: Proceedings of the 
international symposium on standards and codes of practice in medical radiation dosimetry IAEA-CN-
96/82. Vienna: IAEA, 191–99. 
[8] Ferreira IH, Dutreix A, Bridier A, Chavaudra J, Svensson H. 2000. The ESTRO-QUALity assurance network 
(EQUAL). Radiother Oncol, 55: 273–84. 
[9] Izewska J, Andreo P. 2000. The IAEA/WHO TLD postal programme for radiotherapy hospitals. Radiother 
Oncol, 54: 65–72. 
[10] Hussein M., Adams E. J., Jordan T. J., Clark C. H., Nisbet A., 2013. A critical evaluation of the PTW 2D-
ARRAY seven 29 and OCTAVIUS II phantom for IMRT and VMAT verification. J Appl Clin Med Phys. 
14 274 – 92 
[11] Benedict S.H. et al., 2010. Stereotactic body radiation therapy: the report of AAPM Task Group 101. Med 
Phys, 37: 4078–101. 
[12] Jain, P., Baker, A., Distefano, G., Scott, A.J., Webster, G.J., and Hatton, M.Q. Stereotactic ablative 
radiotherapy in the UK: current status and developments. BJR. 2013, 86: 20130331 
(http://dx.doi.org/10.1259/bjr.20130331) 
[13] Izewska J., Svensson H., Ibbott G. 2002. Worldwide quality assurance networks for radiotherapy dosimetry. 
IAEA-CN-96-76. 
[14] Jafari, S. M., Bradley, D. A., Goldstone, C. A., Sharpe, P. H. G., Alalawi, A. I., Jordan, T. J., Clark, C. H., 
Nisbet, A. & Spyrou, N. M. 2014. Low-cost commercial glass beads as dosimeters in radiotherapy. Radiat. 
Phys. Chem., 97; 95-101. 
[15] Jafari, S. M., Jordan, T. J., Hussein, M., Bradley, D. A., Clark, C. H., Nisbet, A. & Spyrou, N. M. 2014. Energy 
response of glass bead TLDs irradiated with radiation therapy beams. Radiation Physics and Chemistry, 
104; 208–211. 
[16] Jafari S.M., Alalawi A. I., Hussein M. , Alsaleh W., Najem M. A., Hugtenburg R.P., Bradley D.A., Spyrou 
N.M., Clark C.H., Nisbet A. 2014. Glass beads and Ge-doped optical fibres as thermoluminescence 
dosimeters for small field photon dosimetry. Phys. Med. Biol. 59 6875-6889. 
[17] Jafari S. M., Jordan T. J., Distefano G., Bradley D. A., Spyrou N. M., Nisbet A., Clark C. H., 2014. Feasibility of 
using glass bead thermo-luminescent dosimeters for radiotherapy treatment plan verification, BJR, 
http://dx.doi.org/10.1259/bjr.20140804  
[18 Jafari S.M.,  Bates N.M., Jupp T. Abdul Sani S.F., Nisbet A., Bradley D.A.  2016. Commercial glass beads as 
TLDs in radiotherapy produced by different manufacturers. Radiation Physics and Chemistry, in press 
[19] IPEM Group, 2010, National Radiotherapy Implementation. Clinical Review of the Evidence for SBRT. IPEM. 
England : NHS, IPEM report 
[20] Chetty I.J. et al. 2007. Report of the AAPM Task Group No. 105: Issues associated with clinical 
implementation of Monte Carlo-based photon and electron external beam treatment planning. Med Phys 34: 
4818-53 
[21] Distefano G., Jafari S. M., Lee J., Gouldstone C., Mayles H., Clark C. H., UK SABR Consortium Lung 
Dosimetry Audit; Absolute dosimetry results. European society for radiotherapy and oncology conference 
(3rd ESTRO Forum) 24-28 April 2015 Barcelona Spain, Radiother. Oncol. Vol. 115, Supplement 1, April 
2015, ISSN 0167-8140, p 96. 
[22] Distefano G., Lee J., Jafari S. M., Gouldstone C., Baker C., Mayles H., , Clark C. H., 2016. A national 
dosimetry audit for stereotactic ablative radiotherapy in lung. Radiother. Oncol. In press. 
[23]Husseina M., Tsang Y., Thomas R.A.S., Gouldstone C., Maughan D., Snaith J.A.D, Bolton S.C., Nisbet A., 
Clark C.H.. 2013. A methodology for dosimetry audit of rotational radiotherapy using a commercial 
detector array Radiother. and Oncol., 108, (1), 78–85 
[24] Sharpe P. H. G., Sephton J. P. 2006. Therapy level alanine dosimetry at the NPL “Alanine Dosimetry for 
Clinical Applications” Proceedings of the 216th PTB Seminar” PTB, Braunschweig 
                                                                                                                                                             
[25] Budgell, G., Berresford, J., Trainer, M., Bradshaw, E., Sharpe, P., and Williams, P. 2011. A national dosimetric 
audit of IMRT. Radiother Oncol. 99 246–252 
[26] Kirby, T.H., Hanson, W.F., Jhonston, D.A., 1992. Uncertainty analysis of absorbed dose calculations from 
thermoluminescence dosimeters. Med. Phys. 19 1427–1433. 
[27] McKerracher, C., Thwaites, D.I., 2006. Notes on the construction of solid-state detectors. Radiother Oncol, 79 
348–351. 
[28] Lechner W., Palmans H., SÖlkner L., Grochowska P. and Georg D., 2013. Detector comparison for small field 
output factor measurements in flattening filter free photon beams Radiother. Oncol. 109 356–60 
[29] Griessbach I., Lapp M., Bohsung J., and Gademann G., 2005. Dosimetric characteristics of a new unshielded 
silicon diode and its application in clinical photon and electron beams. Med. Phys. 32(12), 3750–3754. 
[30] Huang K., Bice W. S. Jr. and Hidalgo-Salvatierra O. 2003. Characterization of an Invivo diode dosimetry 
system for clinical use. J. Appl. Clin. Med. Phys. 4 132–42. 
[31] Ade N., Nam T.L., Derry T.E., Mhlanga S.H., 2014. The dose rate dependence of synthetic diamond detectors 
in the relative dosimetry of high-energy electron therapy beams Radiation Physics and Chemistry 98, 155–
162. 
[32] Wolfsberger L. D., Wagar M., Nitsch P., Bhagwat M. S. And Zygmanski P., 2010. Angular dose dependence of 
Matrixx TM and its calibration J. Appl. Clin. Med. Phys. 11 241-51 
 
 
 
 
 
 
 
 
Highlights:  
 Silica beads have been used as novel micro-TLDs in a national dosimetry audit across 
UK 
 The performance of the TLDs assessed in non-equilibrium conditions near tissue/lung 
interfaces 
 TLDs’ Results agreed well with those obtained from alanine, film and ionisation chamber 
detectors 
